ResMed Inc. (ASX:RMD)

ALERT: Price-sensitive ASX Announcement for RMD

Current share price for RMD : $28.950 -0.83 (-2.79%)⁺

Announcement

Resmed Announces Results for the Third Quarter of FY2026

Release

1 May 2026 8:19AM

Price at Release

$29.780

Full Release

Summary

ResMed Inc. announced their financial results for the third quarter of fiscal year 2026, reporting a revenue increase of 11% to $1.4 billion, with an 8% increase on a constant currency basis. The GAAP gross margin improved by 290 basis points to 62.2%, while the non-GAAP gross margin also rose by 290 basis points to 62.8%. GAAP income from operations increased by 17%, and non-GAAP income from operations rose by 18%. The GAAP diluted earnings per share was $2.74, whereas the non-GAAP diluted earnings per share was $2.86. The company returned $262 million to shareholders through share repurchases and dividends, and operating cash flow was $554 million. ResMed's CEO highlighted the strong global demand for its products and the strategic execution that resulted in these financial improvements.

Key Points

Revenue increased by 11% to $1.4 billion; up 8% on a constant currency basis.
GAAP gross margin up 290 basis points to 62.2%; non-GAAP gross margin up 290 basis points to 62.8%.
GAAP income from operations increased 17%; non-GAAP income from operations up 18%.
GAAP diluted earnings per share of $2.74; non-GAAP diluted earnings per share of $2.86.
Operating cash flow of $554 million; $262 million returned to shareholders through share repurchases and dividends.
Continued strong global demand and disciplined strategic execution.

IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.